Literature DB >> 31656878

Use of Genome Editing Tools in Environmental Health Research.

Julia E Rager1,2,3, Celeste Carberry1, Rebecca C Fry1,2,3.   

Abstract

The nature and types of genome editing tools are rapidly expanding and becoming increasingly incorporated into research efforts aimed at understanding human disease. The majority of research involving genome editing has been driven by medical research, with a limited but increasing number of studies currently published in the field of environmental health and toxicology. This review aims to address this research gap by providing a high-level summary of current genome editing techniques and presenting examples of how some of these techniques have been used toxicologically to evaluate environmental exposure-induced disease. Specific strategies surrounding the evaluation of hazardous chemicals, chemical mechanism of action / adverse outcome pathways, and inter-individual response variability are also discussed to aid in the translation of genome editing methods towards toxicological and environmental health research.

Entities:  

Keywords:  CRISPR-Cas9; Chemicals; Environmental health; Gene editing; Risk assessment; Toxicology

Year:  2019        PMID: 31656878      PMCID: PMC6814161          DOI: 10.1016/j.cotox.2019.02.007

Source DB:  PubMed          Journal:  Curr Opin Toxicol        ISSN: 2468-2020


  23 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

Review 2.  Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.

Authors:  Michael Boettcher; Michael T McManus
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

Review 3.  Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.

Authors:  Hua Shen; Cliona M McHale; Martyn T Smith; Luoping Zhang
Journal:  Mutat Res Rev Mutat Res       Date:  2015-01-25       Impact factor: 5.657

Review 4.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Cortexolone: binding to glucocorticoid receptors in rat thymocytes and mechanism of its antiglucocorticoid action.

Authors:  N Kaiser; R J Milholland; R W Turnell; F Rosen
Journal:  Biochem Biophys Res Commun       Date:  1972-10-17       Impact factor: 3.575

6.  Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme.

Authors:  Richard K Kwok; Rachel B Kaufmann; M Jakariya
Journal:  J Health Popul Nutr       Date:  2006-06       Impact factor: 2.000

Review 7.  Cornerstones of CRISPR-Cas in drug discovery and therapy.

Authors:  Christof Fellmann; Benjamin G Gowen; Pei-Chun Lin; Jennifer A Doudna; Jacob E Corn
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

8.  Chemical quality of maternal drinking water and congenital heart disease.

Authors:  S Zierler; M Theodore; A Cohen; K J Rothman
Journal:  Int J Epidemiol       Date:  1988-09       Impact factor: 7.196

9.  In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.

Authors:  Jatin Roper; Tuomas Tammela; Naniye Malli Cetinbas; Adam Akkad; Ali Roghanian; Steffen Rickelt; Mohammad Almeqdadi; Katherine Wu; Matthias A Oberli; Francisco J Sánchez-Rivera; Yoona K Park; Xu Liang; George Eng; Martin S Taylor; Roxana Azimi; Dmitriy Kedrin; Rachit Neupane; Semir Beyaz; Ewa T Sicinska; Yvelisse Suarez; James Yoo; Lillian Chen; Lawrence Zukerberg; Pekka Katajisto; Vikram Deshpande; Adam J Bass; Philip N Tsichlis; Jacqueline Lees; Robert Langer; Richard O Hynes; Jianzhu Chen; Arjun Bhutkar; Tyler Jacks; Ömer H Yilmaz
Journal:  Nat Biotechnol       Date:  2017-05-01       Impact factor: 54.908

10.  Systems biology and birth defects prevention: blockade of the glucocorticoid receptor prevents arsenic-induced birth defects.

Authors:  Bhavesh K Ahir; Alison P Sanders; Julia E Rager; Rebecca C Fry
Journal:  Environ Health Perspect       Date:  2013-01-03       Impact factor: 9.031

View more
  3 in total

1.  Integrative exposomic, transcriptomic, epigenomic analyses of human placental samples links understudied chemicals to preeclampsia.

Authors:  Alex Chao; Jarod Grossman; Celeste Carberry; Yunjia Lai; Antony J Williams; Jeffrey M Minucci; S Thomas Purucker; John Szilagyi; Kun Lu; Kim Boggess; Rebecca C Fry; Jon R Sobus; Julia E Rager
Journal:  Environ Int       Date:  2022-06-30       Impact factor: 13.352

Review 2.  Review of the environmental prenatal exposome and its relationship to maternal and fetal health.

Authors:  Julia E Rager; Jacqueline Bangma; Celeste Carberry; Alex Chao; Jarod Grossman; Kun Lu; Tracy A Manuck; Jon R Sobus; John Szilagyi; Rebecca C Fry
Journal:  Reprod Toxicol       Date:  2020-02-23       Impact factor: 3.143

Review 3.  New Approach Methods to Evaluate Health Risks of Air Pollutants: Critical Design Considerations for In Vitro Exposure Testing.

Authors:  Jose Zavala; Anastasia N Freedman; John T Szilagyi; Ilona Jaspers; John F Wambaugh; Mark Higuchi; Julia E Rager
Journal:  Int J Environ Res Public Health       Date:  2020-03-23       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.